Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Lixte Biotechnology Holdings, Inc.    LIXT

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

(LIXT)
SummaryQuotesChartsNewsCompany 
Business Summary
Lixte Biotechnology Holdings, Inc., including its subsidiary, Lixte Biotechnology, Inc., is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs compounds to attack those targets. The Company's primary focus is developing new treatments for human cancers. The Company designs drugs for which there are existing data suggesting that they may affect the altered pathways of the cancer cell and may be given safely to humans. This approach has led to the development of over two classes of drugs for the treatment of cancer, consisting of protein phosphatase inhibitors (PTase-i), designated by the Company as the LB-100 series of compounds, and histone deacetylase inhibitors (HDACi), designated by the Company as the LB-200 series of compounds. Compounds of both types also have use in the prevention and treatment of neurodegenerative diseases.
Managers
NameAgeSinceTitle
John S. Kovach, Dr.20182014President, CEO, CFO, Director
Philip F. Palmedo, Dr.20182005Independent Director
Stephen J. Forman, Dr.20182016Director
Yun Yen, Dr.20182018Director
Sze Chun Ho, Dr.20182018Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 67,045,814 9,129,207 13.6% 0 0.0% 13.5%
Stock B 0 350,000 0 0.0% 0 0.0%
Shareholders
NameEquities%
John S. Kovach 9,114,503 13.6%
Gil Schwartzberg 8,823,584 13.2%
John & Barbara Kovach 2015 Trust 8,000,000 11.9%
Arthur Riggs 6,110,000 9.11%
Hung Tak Ho 6,000,000 8.95%
Lalit R. Bahl 6,000,000 8.95%
Robert Greenberg 5,650,000 8.43%
J Lawrence Goldstein 2,000,000 2.98%
Philip F. Palmedo 1,166,020 1.74%
Yun Yen 200,000 0.30%
Company contact information
Lixte Biotechnology Holdings, Inc.
248 Route 25A No. 2
East Setauket, NY 11733

Phone : +1.631.942.7959
Fax : +1.631.982.5050
Web : http://www.lixte.com